Home › Companies › Neurogene Inc. › 2025-2026

Neurogene Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Neurogene Inc.’s Form 8-K, filed 2026-06-04 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Reported items
131Asset managers
818Fund votes
2026-06-03Meeting date

Proxy season: 2024-2025 2025-2026

Explore Neurogene Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Neurogene Inc.

These tallies are Neurogene Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Neurogene Inc. — official shareholder meeting results, meeting held 2026-06-03
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Robert Baffi	9,540,734	--	--	548,736	1,297,937	Majority: yes
Elect Director: Rohan Palekar	10,058,331	--	--	31,139	1,293,937	Majority: yes
Proposal 2: Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers:	9,991,445	36,394	61,631	--	1,297,937	Majority: yes
Proposal 3: Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:	9,345,925	1,939,039	102,443	--	--	Majority: yes

Source: Neurogene Inc., Form 8-K, filed with the SEC on 2026-06-04 — read the filing on EDGAR.

How asset managers voted at the Neurogene Inc. 2025-2026 meeting

Each item below shows how the 131 asset managers that disclosed a Neurogene Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Neurogene Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve on an advisory (non- binding) basis the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 9,991,445AGAINST: 36,394

Neurogene Inc.’s own tally for this item (“Proposal 2: Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers:”): 9,991,445 for, 36,394 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 15,801,901 outstanding shares: 63% for, 0.3% against (63% of the company cast a for/against vote).

The 114 asset managers below cast 85% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 85%AGAINST 15%

FOR: 85.4%AGAINST: 14.6%

Largest asset managers voting on “To approve on an advisory (non- binding) basis the compensation of the Company's named executive officers.” at Neurogene Inc., 2025-2026
Asset manager	For	Against	Vote
Samsara BioCapital, LLC	1,717,127	0	For
Redmile Group, LLC	0	1,446,634	Against
RTW INVESTMENTS, LP	1,362,456	0	For
EcoR1 Capital, LLC	1,271,342	0	For
GREAT POINT PARTNERS LLC	1,000,000	0	For
Fidelity	637,562	0	For
BlackRock	515,066	6,770	For
Trails Edge Capital Partners, LP	402,535	0	For
Casdin Capital, LLC	265,138	0	For
GEODE CAPITAL MANAGEMENT, LLC	251,303	0	For
Vanguard	233,016	0	For
State Street	155,802	160	For
BLAIR WILLIAM & CO/IL	118,705	0	For
Rock Springs Capital Management LP	104,339	0	For
Citadel	88,512	0	For
Northern Trust	67,748	0	For
Woodline Partners LP	63,995	0	For
DAFNA Capital Management LLC	56,635	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	32,765	0	For
Charles Schwab	30,058	0	For
Nuveen	23,910	0	For
TIAA	19,943	0	For
MELLON INVESTMENTS Corp	19,388	0	For
JPMorgan	17,084	0	For
PNC BANK, NATIONAL ASSOCIATION	15,362	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

2. To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 57%1 YEAR 35%

The 100 asset managers below cast 100% of the shares they voted on this item FOR (410,164 for, 0 against).

FOR: 410,164 (6.8%)ONE YEAR: 3,475,459 (57.5%)1 YEAR: 2,090,538 (34.6%)1-YEAR: 63,995 (1.1%)THREE YEARS: 8,979 (0.1%)1.0: 3 (0.0%)

Largest asset managers voting on “To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by t” at Neurogene Inc., 2025-2026
Asset manager	For	Vote
Redmile Group, LLC	0	1 Year
RTW INVESTMENTS, LP	0	One Year
Fidelity	0	One Year
Trails Edge Capital Partners, LP	402,535	For
ArrowMark Colorado Holdings LLC	0	1 Year
Casdin Capital, LLC	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	One Year
Vanguard	0	One Year
State Street	0	One Year
BLAIR WILLIAM & CO/IL	0	One Year
Rock Springs Capital Management LP	0	One Year
Citadel	0	One Year
JENNISON ASSOCIATES LLC	0	1 Year
Woodline Partners LP	0	1-Year
Charles Schwab	0	1 Year
DAFNA Capital Management LLC	0	1 Year
Raiffeisen Bank International AG	0	1 Year
DRIEHAUS CAPITAL MANAGEMENT LLC	0	One Year
BALYASNY ASSET MANAGEMENT L.P.	0	1 Year
Nuveen	0	One Year
TIAA	0	One Year
MELLON INVESTMENTS Corp	0	One Year
JPMorgan	0	One Year
Goldman Sachs	0	One Year
ETFis Series Trust I	0	One Year

Showing the 25 largest of 100 asset managers. See all 100 in the interactive database.

3. To ratify on an advisory (non- binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%

FOR: 9,345,925AGAINST: 1,939,039

Neurogene Inc.’s own tally for this item (“Proposal 3: Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”): 9,345,925 for, 1,939,039 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 15,801,901 outstanding shares: 59% for, 12% against (71% of the company cast a for/against vote).

The 56 asset managers below cast 73% of the shares they voted on this item FOR (1,128,116 for, 419,710 against).

FOR 71%AGAINST 26%

FOR: 1,128,116 (70.9%)AGAINST: 419,710 (26.4%)ABSTAIN: 43,000 (2.7%)

Largest asset managers voting on “To ratify on an advisory (non- binding) basis the appointment of Deloitte & Touche LLP as the Company's indepe” at Neurogene Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	420,181	0	0	For
ArrowMark Colorado Holdings LLC	0	354,220	0	Against
BlackRock	216,323	0	0	For
Vanguard	210,881	107	0	For
JENNISON ASSOCIATES LLC	64,038	0	0	For
Charles Schwab	60,116	0	0	For
Raiffeisen Bank International AG	0	0	43,000	Abstain
BALYASNY ASSET MANAGEMENT L.P.	0	29,328	0	Against
State Street	26,398	0	0	For
TIAA	19,943	0	0	For
JPMorgan	17,084	0	0	For
ETFis Series Trust I	12,416	0	0	For
SEI	0	11,962	0	Against
Lincoln Financial	10,754	0	0	For
ALPS ETF Trust	10,519	0	0	For
Equitable	9,482	0	0	For
Dimensional	8,979	0	0	For
Brighthouse	6,982	0	0	For
Global X	0	5,283	0	Against
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	4,907	0	Against
Bridge Builder Trust	4,657	0	0	For
Pacific Life	4,468	0	0	For
American Century	4,383	0	0	For
NEW YORK STATE COMMON RETIREMENT FUND	0	4,200	0	Against
John Hancock	3,130	0	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

4. Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 9,540,734WITHHELD: 548,736

Neurogene Inc.’s own tally for this item (“Elect Director: Robert Baffi”): 9,540,734 for, 548,736 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 15,801,901 outstanding shares: 60% for, 3% withheld (64% of the company cast a for/withheld vote).

The 40 asset managers below cast 100% of the shares they voted on this item FOR (985,429 for, 0 against).

FOR 94%

FOR: 985,429 (94.1%)ABSTAIN: 61,778 (5.9%)

Largest asset managers voting on “Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D.” at Neurogene Inc., 2025-2026
Asset manager	For	Abstain	Vote
Fidelity	420,181	0	For
BlackRock	216,323	0	For
Vanguard	210,882	106	For
Charles Schwab	30,058	0	For
State Street	26,373	25	For
TIAA	19,943	0	For
JPMorgan	17,084	0	For
ETFis Series Trust I	0	12,416	Abstain
Lincoln Financial	10,754	0	For
ALPS ETF Trust	0	10,519	Abstain
Equitable	1,842	7,640	Abstain
Dimensional	0	8,979	Abstain
Brighthouse	2,785	4,197	Abstain
SEI	5,718	0	For
Global X	5,283	0	For
Bridge Builder Trust	4,657	0	For
Pacific Life	4,468	0	For
American Century	0	4,383	Abstain
John Hancock	0	3,130	Abstain
Goldman Sachs	2,351	0	For
ProShares	0	2,288	Abstain
BRIDGEWAY FUNDS INC	0	1,937	Abstain
Franklin Templeton	1,840	0	For
DWS	0	1,584	Abstain
T. Rowe Price	1,407	0	For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

5. Election of Class III Directors for terms expiring in 2029: Rohan Palekar

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 10,058,331WITHHELD: 31,139

Neurogene Inc.’s own tally for this item (“Elect Director: Rohan Palekar”): 10,058,331 for, 31,139 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 15,801,901 outstanding shares: 64% for, 0.2% withheld (64% of the company cast a for/withheld vote).

The 40 asset managers below cast 100% of the shares they voted on this item FOR (1,037,979 for, 0 against).

FOR 99.1%

FOR: 1,037,979 (99.1%)ABSTAIN: 9,229 (0.9%)

Largest asset managers voting on “Election of Class III Directors for terms expiring in 2029: Rohan Palekar” at Neurogene Inc., 2025-2026
Asset manager	For	Abstain	Vote
Fidelity	420,181	0	For
BlackRock	216,323	0	For
Vanguard	210,765	223	For
Charles Schwab	30,058	0	For
State Street	26,372	26	For
TIAA	19,943	0	For
JPMorgan	17,084	0	For
ETFis Series Trust I	12,416	0	For
Lincoln Financial	10,754	0	For
ALPS ETF Trust	10,519	0	For
Equitable	9,482	0	For
Dimensional	0	8,979	Abstain
Brighthouse	6,982	0	For
SEI	5,718	0	For
Global X	5,283	0	For
Bridge Builder Trust	4,657	0	For
Pacific Life	4,468	0	For
American Century	4,383	0	For
John Hancock	3,130	0	For
Goldman Sachs	2,351	0	For
ProShares	2,288	0	For
BRIDGEWAY FUNDS INC	1,937	0	For
Franklin Templeton	1,840	0	For
DWS	1,584	0	For
T. Rowe Price	1,407	0	For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

6. To hold a non-binding advisory vote on whether future non-binding advisory votes on the executive compensation paid by the company to its named executive officers should be held every one, two, or three years.

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 99.9%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 1,619,077 (100.0%)3 YEARS: 17 (0.0%)

Largest asset managers voting on “To hold a non-binding advisory vote on whether future non-binding advisory votes on the executive compensation” at Neurogene Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
GREAT POINT PARTNERS LLC	0	0	0	0	1 Year
BlackRock	0	0	0	0	1 Year
Northern Trust	0	0	0	0	1 Year
PNC BANK, NATIONAL ASSOCIATION	0	0	0	0	1 Year
Bridge Builder Trust	0	0	0	0	1 Year
John Hancock	0	0	0	0	1 Year
D.A. DAVIDSON & CO.	0	0	0	0	1 Year
MERCER GLOBAL ADVISORS INC /ADV	0	0	0	0	1 Year
WILSHIRE MUTUAL FUNDS INC	0	0	0	0	1 Year
MML INVESTORS SERVICES, LLC	0	0	0	0	1 Year
WELLS FARGO BANK N A	0	0	0	0	1 Year
SmartHarvest Portfolios, LLC	0	0	0	0	1 Year
Savant Capital, LLC	0	0	0	0	1 Year
NORDEN GROUP LLC	0	0	0	0	1 Year
Pathstone Holdings, LLC	0	0	0	0	1 Year
Bleakley Financial Group, LLC	0	0	0	0	1 Year
Frec Advisers LLC	0	0	0	0	1 Year
FIRST AMERICAN TRUST, FSB	0	0	0	0	1 Year
Sanctuary Advisors, LLC	0	0	0	0	1 Year
GAMMA Investing LLC	0	0	0	0	1 Year
Perigon Wealth Management, LLC	0	0	0	0	3 Years
ENVESTNET ASSET MANAGEMENT INC	0	0	0	0	1 Year
WELLS FARGO CLEARING SERVICES, LLC	0	0	0	0	1 Year
BOYD WATTERSON ASSET MANAGEMENT LLC/OH	0	0	0	0	1 Year
Alteri Wealth LLC	0	0	0	0	1 Year

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

7. To hold an advisory (non-binding) vote on whether future non-binding advisory votes on the compensation paid by the Company to its named executive officers should be held every one, two or three years

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,271,342 for, 0 against).

FOR: 1,271,342 (100.0%)

Largest asset managers voting on “To hold an advisory (non-binding) vote on whether future non-binding advisory votes on the compensation paid b” at Neurogene Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
EcoR1 Capital, LLC	1,271,342	0	0	0	For
IPConcept (Luxemburg) S.A.	0	0	0	0	--

Largest Neurogene Inc. shareholders voting in 2025-2026

Ranked by the number of Neurogene Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 15,801,901 shares outstanding at the time of that meeting.

Top Neurogene Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Samsara BioCapital, LLC	10.87%
2	Redmile Group, LLC	9.15%
3	RTW INVESTMENTS, LP	8.62%
4	EcoR1 Capital, LLC	8.05%
5	GREAT POINT PARTNERS LLC	6.33%
6	Fidelity	4.03%
7	BlackRock	3.30%
8	Trails Edge Capital Partners, LP	2.55%
9	Casdin Capital, LLC	1.68%
10	GEODE CAPITAL MANAGEMENT, LLC	1.59%

Reported Neurogene Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Neurogene Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Samsara BioCapital, L.P.	10.95%	DEF14A
Entities affiliated with Baker Brothers Investments	10.28%	DEF14A
Entities affiliated with EcoR1 Capital Fund, L.P.	10.09%	DEF14A
Entities affiliated with RTW Investments, LP	10.03%	DEF14A
Entities affiliated with Redmile Group, LLC	9.95%	DEF14A
Redmile Group, LLC	9.95%	13G
Rachel McMinn	9.02%	DEF14A
Entities affiliated with Casdin Capital, LLC	8.20%	DEF14A
Entities affiliated with BlackRock Capital Management, Inc.	6.40%	DEF14A
Entities affiliated with Trails Edge Capital Partners, LP	4.97%	DEF14A

Percentages above are of 15,801,901 shares outstanding, as reported by Neurogene Inc. on its Form 10-Q dated 2026-05-08 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Neurogene Inc.’s 10-Q dated 2026-05-08. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Neurogene Inc.'s shareholder meeting held 2026-06-03, in the 2025-2026 proxy season, 131 asset managers reported how they voted in their SEC Form N-PX filings, covering 818 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve on an advisory (non- binding) basis the compensation of the Company's named… — FOR was 99.6% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Neurogene Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-04.

Neurogene Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).